Background The long‐term risk of stroke increases with age, and stroke is a common cause
of disability in the community. Spasticity is considered a significantly disabling impairment …

Objective: Does early treatment of spasticity with botulinum-toxin (BoNTA), in (hyper) acute
stroke patients without arm-function, reduce contractures and improve function. Design …

OBJECTIVE: The cutaneous silent period (SP) is a spinal inhibitory reflex, which suppresses
activity in spinal motor nuclei. Transcranial magnetic stimulation (TMS) elicits a cortical SP …

Spinal cord injury (SCI) is one of the most challenging medical issues. Spasticity is a major
complication of SCI. A combination of spinal cord stimulation, new methods of …

Introduction Accumulating evidence suggests that motor skill training is associated with
structural and functional reorganization of the primary motor cortex. However, previous …

When walking on a split-belt treadmill where one belt moves faster than the other, the
nervous system consistently attempts to maintain symmetry between legs, quantified as …

Baclofen is a GABAB receptor agonist commonly used to relief spasticity related to motor
disorders. The effects of baclofen on voluntary motor output are limited and not yet …

Study design: Transcranial magnetic stimulation study. Objectives: To further investigate the
corticospinal excitability changes after spinal cord injury (SCI), as assessed by means of …

Exaggerated sensory activity has been assumed to contribute to functional impairment
following lesion of the central motor pathway. However, recent studies have suggested that …

Motor learning has been linked with increases in corticospinal excitability (CSE). However,
the robustness of this link is unclear. In this study, changes in CSE associated with learning …